News

ELITechGroup

Filter

Open filter menu
Reset
Reset

New Advancement in Cystic Fibrosis

Cystic fibrosis is a genetic disease that affects more than 70,000 people worldwide, with another 1,000 diagnosed with the disease each year. There are more than 1,700 known mutations of cystic fibrosis, complicating efforts to treat the disease. A new advancement in cystic fibrosis treatment involves growing mini-organs in a…

Zika ELITe MGB® Kit U.S. nominated for Best New Clinical Product of 2016!

Nominated! Zika ELITe MGB® Kit U.S. Each year the SelectScience® Scientists’ Choice Awards® celebrates the laboratory products and manufacturers that make a difference to the industry. This year, ELITechGroup’s EUA assay Zika ELITe MGB® Kit U.S. has been nominated for “Best New Clinical Product of 2016”. This cost-effective, high-performing Real-Time…

ELITechGroup Molecular Diagnostics announces the CE-IVD marking of the STI ELITe MGB® Panel, for the detection of C. trachomatis, N. gonorrhoeae and M. genitalium

Puteaux, France, 9th June 2017 – ELITechGroup Molecular Diagnostics announces the CE-IVD marking of the STI ELITe MGB® Panel: a multiplex assay for the detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Mycoplasma genitalium (MG), three major bacteria involved in Sexually Transmitted Infections. STIs are a global burden with more than 1…

ELITechGroup Molecular Diagnostics announces the CE-IVD marking of the Meningitis Viral 2 ELITe MGB® Panel for the detection of Enterovirus, Parechovirus, and Adenovirus with ELITe InGenius®

Puteaux, France, 6th July 2017 – ELITechGroup Molecular Diagnostics, announces today the launch of a high-performance real-time PCR assay: Meningitis Viral 2 ELITe MGB® Panel for viral meningitis diagnosis, validated with ELITe InGenius, ELITechGroup’s fully automated sample to result system.   To read more >>EMD PR Meningitis 201707“

ELITechGroup Molecular Diagnostics announces the CE-IVD marking of the STI ELITe MGB® Panel, for the detection of C. trachomatis, N. gonorrhoeae and M. genitalium

Puteaux, France, 9th June 2017 – ELITechGroup Molecular Diagnostics announces the CE-IVD marking of the STI ELITe MGB® Panel: a multiplex assay for the detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Mycoplasma genitalium (MG), three major bacteria involved in Sexually Transmitted Infections. STIs are a global burden with…

Molecular Diagnostics CVS Workshop

CVS 2017 Workshop ELITechGroup Molecular Diagnostics will be hosting an exclusive workshop at this year’s ASM Clinical Virology Symposium in Savannah, GA. The workshop will include lectures from distinguished speakers describing their experience using ELITe InGenius®, the highly flexible sample-to-result system designed for Molecular laboratories. Time & Location: Monday, May…

ELITechGroup SYMPOSIUM

Monday 24th April 2017 (Vienna – Austria) ELITechGroup Symposium (Molecular Diagnostics) : ELITe InGenius® the highly flexible sample-to-result solution (program) ELITechGroup Symposim (Microbiology) : Introducing the Rapid Polymyxin NP™ and Superpolymyxin™ tests, 2 new solutions for detecting and isolating Colistin-resistant strains (program) Contact your local representative for further information.”

Highlighting Vapor Pressure Osmometers

Vapor pressure osmometers are an essential mainstay in laboratories worldwide in research osmometry. ELITechGroup Biomedical Systems is the undisputed leader of vapor pressure osmometers, bringing both superior quality, methodology and accuracy to the process. Processing viscous, fluid or solid tissue specimens, ELITechGroup’s unique osmometers enables users to easily and quickly…

Highlighting Sweat Testing Products

Sweat-Chek™ Analyzer The sooner you get diagnosed with cystic fibrosis, the sooner you can start treatment to improve your quality of life and your lifespan. Known globally as the leader in a laboratory diagnosis of cystic fibrosis, ELITechGroup Biomedical Systems proudly offers several products to help with early diagnosing of…

ELITechGroup Molecular Diagnostics announced the CE-IVD marking of the Coagulation ELITe MGB® Kit, a multiplex assay for the detection of Factor V, Factor II, and MTHFR genetic variants

Puteaux, France, 27th January 2017 – ELITechGroup Molecular Diagnostics announced today the CE-IVD marking of the Coagulation ELITe MGB® Kit, a high-performance, multiplex assay for the detection of genetic variants associated with higher risk of deep venous thrombosis. Deep venous thrombosis is a multifactorial disease and major health problem which…

ELITe InGenius® Aids Fight Against Zika

Zika ELITe MGB® Kit U.S. and ELITe InGenius, the fully automated sample-to-result system, has joined the fight against the Zika virus. In December, ELITechGroup received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the Zika ELITe MGB Kit U.S. used in combination with ELITe InGenius.…

ELITechGroup receives FDA Emergency Use Authorization for Zika ELITe MGB® Kit U.S. performed using the ELITe InGenius™ instrument

Puteaux, France, December 9th, 2016 – ELITechGroup announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the Zika ELITe MGB® Kit U.S. performed using the ELITe InGenius™ instrument, a fully automated sample-to-result system. This real-time PCR-based test utilizes ELITechGroup Molecular Diagnostics…

ELITechGroup Announces Agreement with Abbott to Expand Distribution Channels

Puteaux, France November 9th, 2016 – ELITechGroup today announced a U.S. distribution agreement, with Abbott’s Molecular business, for molecular diagnostic reagents. The reagents target a range of genes associated with virus activity in patients that have undergone organ or hematopoietic stem cell transplantation. Additional products included within the agreement focus…

ELITechGroup Molecular Diagnostics announce the CE-IVD marking of the CRE ELITe MGB® Kit, for the detection of the Carbapenem Resistance genes of Enterobacteriaceae

Puteaux, France November 8th, 2016 – ELITechGroup Molecular Diagnostics announce today the CE-IVD marking of the CRE ELITe MGB® kit, a high-performance, qualitative, multiplex assay for the rapid detection of the Carbapenem Resistance genes of Enterobacteriaceae. In combination with the ELITe InGenius™, the ELITech Group’s fully automated sample-to-result system, the…

Molecular Diagnostics Advances Research and Treatment

The molecular diagnostics market is one of the fastest-growing segments in the medical diagnostics industry today. According to a study done by DPI Research, the market is projected to reach more than $30 billion by the year 2021. That makes it the largest segment of the in vitro diagnostic (IVD)…

Cystic Fibrosis Can Lead to Other Conditions

Macroduct Advanced and Baby
If you suffer from Cystic Fibrosis, then you already know the struggles associated with having the disease, but can CF lead to more? Recent studies have shown that it might. In a study published in the Cystic Fibrosis Journal, researchers were eager to determine the effects of Cystic Fibrosis and…

Hematology Industry Expected to Grow to $2.6B by 2020

The global hematology analyzers market is expected to grow to more than $2.6 billion by 2020, according to a recent study by technology advisory and research firm Technavio. The Technavio market report includes a detailed exploration of market trends and revenue for the industry and explores forecasts for different regions…

PSS and ELITechGroup reach OEM Agreement

Jan 7, 2015 Matsudo, Japan and Paris, France, January 5, 2015 – Precision System Science, Co., Ltd. (PSS) and The ELITech Group (ELITech) jointly announce that the companies have extended their relationship into a Development and Supply Agreement.Under and an exclusive OEM arrangement, PSS will develop and supply “geneLEADXII” instrument,…